Medycyna Paliatywna

Abstract

3/2022 vol. 14
Review paper

Delirium in cancer patient

  1. Oddział Medycyny Paliatywnej, Szpital Uniwersytecki w Krakowie, Kraków, Polska
  2. Klinika Leczenia Bólu i Opieki Paliatywnej, Katedra Chorób Wewnętrznych i Gerontologii, Collegium Medicum Uniwersytet Jagielloński, Kraków, Polska
  3. Centrum Onkologiczne, Wojewódzki Szpital im. Zofii z Zamoyskich Tarnowskiej, Tarnobrzeg, Polska
Medycyna Paliatywna 2022; 14(3): 142–154
Online publish date: 2023/04/18
View full text
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
Delirium is an acute disturbance of consciousness usually occurring in elderly patients and secondary to worsening somatic condition. Dementia is the main risk factor. Delirium may be a symptom of infection, electrolyte disturbances, changes in pharmacologic treatment, or as a response to pain or hypoxaemia. In patients with diagnosed neoplastic disease, it is more commonly caused by hypercalcaemia, primary and secondary neoplasms in the CNS, or treatment (glucocorticosteroids, chemotherapy, radiotherapy of the head and neck region). The main management strategy in delirium is the identification and treatment of its causes. Pharmacological interventions should be administered rarely and for as short a time as possible. Prevention plays a critical role and includes avoiding drugs contraindicated in elderly patients (e.g. anticholinergics) and polypharmacy, promoting proper circadian rhythm, avoiding immobilization, correcting sensory deficits (audio and visual impairment), and proper hydration.
Share
without publication fees
without publication fees